RNAi technology makes it possible to target the genes that cause disease.
Treating diseases with significant unmet needs demands a unique approach at a fast pace, that’s exactly where we thrive. Our targeted RNAi molecule, TRiM™, platform leverages a natural pathway to “silence” genes causing disease. With drug candidates in a growing number of disease areas, TRiM™ has shown it can target genes wherever they are.
What We Do Best
Every day we can save in our development timeline is one day earlier a person may benefit from our future therapies.
We go farther when we work together to reimagine how therapeutics are developed and delivered.
We don’t let uncertainty keep us from tackling big questions and finding meaningful solutions.
Above & Beyond
Our goal is to have 20 individual products, either partnered or wholly owned, in clinical trials or on the market by 2025. See how we’re already on the way to achieving our ambitious vision.
There is no shortage of needs that we can endeavor to serve. As scientific explorers, we use our discoveries to develop solutions for the people who need them most.
Our clinical trials are an essential part of our research. Discover the medicines that we’re currently developing.
Patients & Caregivers
Every day matters to patients and their caregivers.
See how we’re making our products available as
quickly as possible.
Careers at Arrowhead
Become part of the team who is leading the market through scientific innovation.